Maximising the potential of AKT inhibitors as anti-cancer treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Maximising the potential of AKT inhibitors as anti-cancer treatments

Published:2017-04 Issue: Volume:172 Page:101-115
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Brown Jessica S.,Banerji Udai

Funder

Cancer Research UK

Experimental Cancer Medicine Centre

National Institute for Health Research Biomedical Research Centre

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference162 articles.

1. Association of AKT1E17K and PIK3CAH1047R mutations with efficacy of ARQ 092 in vitro, in vivo and in patients;Abbadessa;Molecular Cancer Therapeutics,2015

2. Results of an abbreviated phase-II study with the Akt inhibitor MK-2206 in patients with advanced biliary cancer;Ahn;Scientific Reports,2015

3. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase;Alessi;FEBS Letters,1996

4. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha;Alessi;Current Biology,1997

5. Phase II trial of trametinib in combination with the AKT inhibitor GSK 2141795 in BRAF wild-type melanoma;Algazi,2015

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wighteone, a prenylated flavonoid from licorice, inhibits growth of SW480 colorectal cancer cells by allosteric inhibition of Akt;Journal of Ethnopharmacology;2024-08

2. The value of protein allostery in rational anticancer drug design: an update;Expert Opinion on Drug Discovery;2024-07-28

3. An in silico approach to identify novel and potential Akt1 (protein kinase B-alpha) inhibitors as anticancer drugs;Molecular Diversity;2024-05-26

4. Immunometabolism in cancer: basic mechanisms and new targeting strategy;Cell Death Discovery;2024-05-16

5. AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data;Briefings in Bioinformatics;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3